While most research has focused on gut and tendon healing, its anti-inflammatory mechanisms are relevant to skin conditions

Already in effect (January 1, 2026): Standard PA decisions within 7 calendar days (down from 14) Urgent PA decisions within 72 hours Specific denial reasons required on every denial (not just not medically necessary) Applies to Medicare Advantage, Medicaid managed care, CHIP, and ACA Marketplace plans Coming March 31, 2026: Payers must publicly report PA metrics for calendar year 2025: approval/denial rates, average decision times, and appeals outcomes Providers will be able to compare payer performance for the first time Coming January 1, 2027: FHIR-based Prior Authorization APIs required providers check PA requirements, submit requests, and receive decisions electronically through their EHR Expected to reduce average PA processing time from days to minutes for standard requests Medicare WISeR Model (live in AZ and WA): The Wasteful and Inappropriate Services Reduction pilot launched January 2026 in six states including Arizona and Washington

Neither compound is approved by the FDA for human or veterinary therapeutic use
In its absence, peripheral neuropathy can occur, leading to numbness in your extremities
10.1089/ars.2017.7462 Antioxid Redox Signal
What follows is extrapolated from published rat and mouse studies, where tissue repair endpoints were measured at specific time points